{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:03Z","timestamp":1786998303234,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ygyno.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:58:30Z","timestamp":1739782710000},"page":"51-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer"],"prefix":"10.1016","volume":"194","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn B.","family":"Furey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie B.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2025.02.012_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2025.02.012_bb0010","series-title":"Uterine Neoplasms. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)","year":"2022"},{"issue":"10333","key":"10.1016\/j.ygyno.2025.02.012_bb0015","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ygyno.2025.02.012_bb0020","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.annonc.2022.05.009","article-title":"Endometrial cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Oaknin","year":"2022","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.02.012_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2025.02.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113316","article-title":"Validation of the 2023 FIGO staging schema for advanced endometrial cancer","volume":"193","author":"Matsuo","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2025.02.012_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ygyno.2024.04.016","article-title":"Prognostic performance of the 2023 FIGO staging schema for endometrial cancer","volume":"187","author":"Matsuo","year":"2024","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.02.012_bb0040","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ygyno.2021.02.017","article-title":"Sentinel lymph node (SLN) isolated tumor cells (ITCs) in otherwise stage I\/II endometrioid endometrial cancer: to treat or not to treat?","volume":"161","author":"Backes","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2025.02.012_bb0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ijgc-2023-005032","article-title":"Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study","volume":"34","author":"Cucinella","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.012_bb0050","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0988","article-title":"Lymph node isolated tumor cells in patients with endometrial Cancer","volume":"7","author":"Matsuo","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.012_bb0055","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ygyno.2019.02.027","article-title":"Low-volume disease in endometrial cancer: the role of micrometastasis and isolated tumor cells","volume":"153","author":"Bogani","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.02.012_bb0060","author":"National Cancer Database"},{"issue":"10","key":"10.1016\/j.ygyno.2025.02.012_bb0065","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/ijgc-2024-005677","article-title":"Secondary databases in gynecologic cancer research","volume":"34","author":"Hicks-Courant","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2025.02.012_bb0070","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/ijgc-2023-005173","article-title":"Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study","volume":"34","author":"De Vitis","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2025.02.012_bb0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2022.02.015","article-title":"Characterizing isolated tumor cells in regional lymph nodes of early endometrial cancer","volume":"165","author":"Matsuo","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.02.012_bb0080","series-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","year":"2007"},{"issue":"2","key":"10.1016\/j.ygyno.2025.02.012_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"5","key":"10.1016\/j.ygyno.2025.02.012_bb0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181f39849","article-title":"Comparative performance of the 2009 international federation of gynecology and obstetrics\u2019 staging system for uterine corpus cancer","volume":"116","author":"Lewin","year":"2010","journal-title":"Obstet. Gynecol."},{"issue":"18","key":"10.1016\/j.ygyno.2025.02.012_bb0095","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/cncr.26030","article-title":"Does the revised International Federation of Gynecology and Obstetrics staging system for endometrial cancer lead to increased discrimination in patient outcomes?","volume":"117","author":"Cooke","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2025.02.012_bb0100","series-title":"Debate: Keep it Simple Staging SGO 2024 Annumal Meeting on Women\u2019s Cancer. San Diego","author":"Olawaiye","year":"2024"},{"issue":"7447","key":"10.1016\/j.ygyno.2025.02.012_bb0105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.ygyno.2025.02.012_bb0110","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.20.00549","article-title":"Molecular classification of the PORTEC-3 trial for high-risk endometrial Cancer: impact on prognosis and benefit from adjuvant therapy","volume":"38","author":"Leon-Castillo","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2025.02.012_bb0115","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa2302312","article-title":"Pembrolizumab plus chemotherapy in advanced endometrial Cancer","volume":"388","author":"Eskander","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.ygyno.2025.02.012_bb0120","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa2216334","article-title":"Dostarlimab for primary advanced or recurrent endometrial Cancer","volume":"388","author":"Mirza","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.ygyno.2025.02.012_bb0125","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1200\/JCO.2017.76.5966","article-title":"Randomized phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-Trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor receptor 2\/neu","volume":"36","author":"Fader","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.02.012_bb0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejogrb.2022.06.018","article-title":"Association between sentinel lymph node biopsy and micrometastasis in endometrial cancer","volume":"275","author":"Matsuo","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2025.02.012_bb0135","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1245\/s10434-023-13310-z","article-title":"Cancer stage-shifting with sentinel lymph node biopsy in low-grade endometrial Cancer","volume":"30","author":"Matsuo","year":"2023","journal-title":"Ann. Surg. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:42:59Z","timestamp":1762231379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":27,"alternative-id":["S0090825825000484"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.02.012","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histology-specific prognostic significance of isolated tumor cells, micrometastases, and macrometastases in endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}